专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明专利

GB202013150D0 Anti-error refueling control platform and method 未知
公开(公告)号：GB202013150D0
公开(公告)日：2020-10-07
申请号：GB202013150
申请日：2020-08-24
申请人： WANG JIE

2. 发明专利

AU2021106298A4 Method for monitoring and evaluating pipeline leakage of LNG terminal wharf 未知
公开(公告)号：AU2021106298A4
公开(公告)日：2021-11-04
申请号：AU2021106298
申请日：2021-08-21
申请人： UNIV GUILIN ELECTRONIC TECH , WANG JIE
发明人： WANG JIE , CUI YIWEN , MING ZHICHAO , ZHOU RUPENG , WANG LONG , ZHANG CHAOLI , YUAN TONGXI
IPC分类号： G06N5/00 , F17D5/00 , F17D5/02 , G06F17/10
摘要： The invention discloses a method for monitoring and evaluating pipeline leakage of an LNG (Liquefied Natural Gas) receiving station wharf, which comprises the following steps: quantitatively detecting the flow of liquefied natural gas in the pipeline and the pressure of liquefied natural gas on the pipeline by a wireless sensor network node; An expert system for determine an initial confidence rule base according to expert experience or domain knowledge; Establish a confidence rule base expert system with activation rate and optimize the initial confidence rule base expert system; Through the optimized expert system of confidence rule base, the pipeline leakage of LNG terminal is evaluated, and the evaluation report is obtained. The method has the advantages that the concept of activation rate is used, and the rules which are never activated or are not activated enough can be trimmed in the optimization process. Even if there is a complete data set and all the rules are activated, the activation rate can be used in the parallel optimization process of BRB expert system, and effectively solve the problem of BRB combination explosion. It can make full use of quantitative data and improve the reliability of results without destroying the original explanation provided by experts. Collect pipeline flow and pressure data Establish BRB expert system BRB Expert System with Activation Ratej Evaluation result Figure 1

3. 发明专利

AU3258402A Electronic voting system 未知
公开(公告)号：AU3258402A
公开(公告)日：2002-06-18
申请号：AU3258402
申请日：2001-12-05
申请人： UNIV NORTH CAROLINA AT GREENSB , KARRO JARED , WANG JIE
发明人： KARRO JARED , WANG JIE
IPC分类号： G07C13/00

4. 实用新型

TW387462U Assembly ground grid of yard 失效
公开(公告)号：TW387462U
公开(公告)日：2000-04-11
申请号：TW88216712
申请日：1999-09-30
申请人： SHEN YU TING , WANG JIE LUNG
发明人： SHEN YU-TING , WANG JIE-LUNG
IPC分类号： E04F15/10

5. 发明申请

WO2013166618A1 PRODRUGS OF 4,9-DIHYDROXY-NAPHTHO[2,3-b]FURANS FOR CIRCUMVENTING CANCER MULTIDRUG RESISTANCE 审中-公开
标题翻译： 4,9-二羟基萘并[2,3-b]呋喃类抗癌多药耐药性的研究进展
公开(公告)号：WO2013166618A1
公开(公告)日：2013-11-14
申请号：PCT/CN2012/000618
申请日：2012-05-08
申请人： ZHOUSHAN HAIZHONGZHOU XINSHENG PHARMACEUTICALS CO., LTD. , JIANG, Zhiwei , HU, Yuesong , WANG, Jie , YE, Yan , LI, Xian , XU, Hairong , YANG, Huanhuan , FU, Yaner
发明人： JIANG, Zhiwei , HU, Yuesong , WANG, Jie , YE, Yan , LI, Xian , XU, Hairong , YANG, Huanhuan , FU, Yaner
IPC分类号： C07D307/92 , A61K31/343 , A61P35/00
CPC分类号： A61K31/343
摘要： The present invention discloses use of prodrug of 4,9-dihydroxy-naphtho[2,3-b]furan derivative for circumventing cancer multidrug resistance. The present invention also discloses use of prodrug of 4,9-dihydroxy-naphtho[2,3-b]furan derivative for the treatment of various types of cancers exhibiting multidrug resistance phenomenon. The present invention further discloses use of the pharmaceutically acceptable composition comprising prodrug of 4,9- dihydroxy-naphtho[2,3-b]furan derivative and method of using said composition in the treatment of various types of cancers exhibiting multidrug resistance phenomenon.
摘要翻译：本发明公开了4,9-二羟基 - 萘并[2,3-b]呋喃衍生物的前药用于避免癌症多药耐药性。本发明还公开了4,9-二羟基 - 萘并[2,3-b]呋喃衍生物的前药用于治疗表现出多药耐药现象的各种类型的癌症。本发明还公开了包含4,9-二羟基 - 萘并[2,3-b]呋喃衍生物的前药的药学上可接受的组合物的用途和使用该组合物治疗表现出多药耐药现象的各种类型的癌症的方法。

6. 发明申请

WO2013030738A1 SYSTEM AND METHOD FOR LOCATING AND IDENTIFYING FUNCTIONAL NERVES INNERVATING WALL OF ARTERIES 审中-公开
标题翻译：用于定位和识别功能性神经内分泌器官的系统和方法
公开(公告)号：WO2013030738A1
公开(公告)日：2013-03-07
申请号：PCT/IB2012/054303
申请日：2012-08-24
申请人： SYMAP MEDICAL LIMITED , WANG, Jie
发明人： WANG, Jie
IPC分类号： A61B5/00 , A61B18/12 , A61B18/00
CPC分类号： A61B18/1492 , A61B5/0205 , A61B5/0215 , A61B5/024 , A61B5/04001 , A61B5/0538 , A61B5/201 , A61B5/4833 , A61B5/4836 , A61B5/4893 , A61B5/6852 , A61B5/6853 , A61B18/18 , A61B18/24 , A61B2018/00404 , A61B2018/00434 , A61B2018/00505 , A61B2018/00511 , A61B2018/00577 , A61B2018/00642 , A61B2018/00708 , A61B2018/00791 , A61B2018/00839 , A61B2018/00875 , A61N1/36117 , A61N7/02 , A61N2007/003 , G06F19/00
摘要： System and method for locating and identifying nerves innervating the wall of arteries such as the renal artery are disclosed. The present invention identifies areas on vessel walls that are innervated with nerves; provides indication on whether a dose of energy is delivered accurately to a targeted nerve; and provides immediate post-procedural assessment of the effect of the energy delivered to the nerve. The method includes at least the steps to evaluate a change in physiological parameters after a dose of energy is delivered to an arterial wall; and to determine the type of nerve that the energy was directed to (none, sympathetic or parasympathetic) based on the results of the evaluation. The system includes at least a device for delivering a dose of energy to the wall of an artery; sensors for detecting physiological signals from a subject; and indicators to display the results obtained using the said method.
摘要翻译：公开了用于定位和识别支配动脉壁如肾动脉的神经的系统和方法。本发明识别血管壁上神经支配的区域; 提供能量准确地传递到目标神经的指示; 并提供对传递给神经的能量的影响的即时的程序后评估。该方法至少包括以下步骤：在将能量的剂量输送到动脉壁之后评估生理参数的变化; 并根据评估结果确定能量指向的神经类型（无，交感神经或副交感神经）。该系统至少包括用于向动脉壁递送一定能量的能量的装置; 用于检测来自受试者的生理信号的传感器; 并显示使用所述方法获得的结果的指标。

7. 发明申请

WO2011140682A8 (2E)-3-PHENYL-N-[2,2,2-TRIFLUORO-1-[[(8-QUINOLINEAMINO)THIOMETHYL]AMINO]ETHYL]-2-ACRYLAMIDE AND PHARMACEUTICAL USES THEREOF 审中-公开
标题翻译：（2E）-3-苯基-N- [2,2,2-三氟-1 - [[（8-喹啉氨基）甲基]氨基]乙基] -2-丙烯酰胺及其药物用途
公开(公告)号：WO2011140682A8
公开(公告)日：2012-11-29
申请号：PCT/CN2010000688
申请日：2010-05-14
申请人： CHINESE PLA GENERAL HOSPITAL , HE KUNLUN , LI SONG , WANG LILI , LI XIN , ZHONG WU , HU GUOLIANG , WANG JIE , LI RUIJUN , LIU CHUNLEI , XIAO JUNHAI , LONG LONG , LI WEI , CHEN HUA
发明人： HE KUNLUN , LI SONG , WANG LILI , LI XIN , ZHONG WU , HU GUOLIANG , WANG JIE , LI RUIJUN , LIU CHUNLEI , XIAO JUNHAI , LONG LONG , LI WEI , CHEN HUA
IPC分类号： C07D215/38 , A61K31/47 , A61P9/00
CPC分类号： C07D215/40 , A61K31/47
摘要： Acrylamide compounds of formula (I), or their isomers, pharmaceutically acceptable salts and solvates. Compositions containing said compounds or their isomers, pharmaceutically acceptable salts and solvates, and their pharmaceutically acceptable carriers, excipients or diluents. Uses of said compounds or said compositions for prevention and/or treatment of diseases or disorders related to myocardial cells apoptosis.
摘要翻译：式（I）的丙烯酰胺化合物或其异构体，药学上可接受的盐和溶剂合物。含有所述化合物或其异构体的组合物，药学上可接受的盐和溶剂化物，及其药学上可接受的载体，赋形剂或稀释剂。所述化合物或所述组合物用于预防和/或治疗与心肌细胞凋亡相关的疾病或病症的用途。

8. 发明申请

WO2011116732A3 METHOD, EQUIPMENT AND COMMUNICATION SYSTEM FOR MOBILE TERMINAL ACCESSING WIRELESS NETWORK 审中-公开
标题翻译：移动终端接入无线网络的方法，设备和通信系统
公开(公告)号：WO2011116732A3
公开(公告)日：2012-04-19
申请号：PCT/CN2011073580
申请日：2011-04-29
申请人： HUAWEI DEVICE CO LTD , WANG JIE
发明人： WANG JIE
IPC分类号： H04W48/02
CPC分类号： H04W60/00
摘要： The embodiments of the present invention relate to the electronic communication field, and especially relate to a method, equipment and communication system for a mobile terminal accessing wireless network. The method of the embodiments in the present invention comprises: the mobile terminal sends a user identification of said mobile terminal to a Femtocell through Near Field Communication (NFC) when the mobile terminal closes to the Femtocell and enters the NFC range of the Femtocell and the mobile terminal; wherein, said mobile terminal and said Femetocell both support NFC (11); the Femtocell forwards the received user identification of the mobile terminal to a server (12); after having added the received user identification of the mobile terminal to the Femtocell access user list, the server transmits an access success notice to the mobile terminal (13); after having received the access success notice transmitted by the server, the mobile terminal accesses a wireless network using the Femtocell (14). In the method, equipment and communication system provided by the embodiments of the present invention, because the user identification of said mobile terminal is transmitted by the mobile terminal through NFC to the Femtocell, and forwarded to the server by the Femtocell, the server finishes updating the access user list of the Femtocell, the mobile uses the Femtocell to access the wireless network, the course for the user contacting the administrators of the provider by phone to update the Femtocell access user list is omitted, thus the wasting time is reduced and the fault that manual operation may result in is avoided. So the problem of the operation time being long, the operation course being complex, and error ratio being high for accessing can be solved. Therefore, the method, equipment and communication system provided by the embodiments of the present invention can provide a simple, fast and exact method for updating a list, consequently the mobile terminal can quickly access the wireless network.
摘要翻译：本发明的实施例涉及电子通信领域，特别涉及用于接入无线网络的移动终端的方法，设备和通信系统。本发明实施例的方法包括：当移动终端关闭毫微微蜂窝并进入毫微微蜂窝的NFC范围时，移动终端通过近场通信（NFC）向毫微微小区发送所述移动终端的用户标识，并且移动终端; 其中，所述移动终端和所述Femetocell都支持NFC（11）; 毫微微小区将接收到的移动终端的用户标识转发到服务器（12）; 在将接收到的移动终端的用户标识添加到毫微微蜂窝接入用户列表之后，服务器向移动终端发送访问成功通知（13）; 在接收到由服务器发送的访问成功通知之后，移动终端使用毫微微蜂窝（14）访问无线网络。在由本发明的实施例提供的方法，设备和通信系统中，由于移动终端的用户标识由移动终端通过NFC发送到毫微微蜂窝，并由毫微微蜂窝小区转发到服务器，服务器完成更新毫微微蜂窝的接入用户列表，移动台使用毫微微蜂窝基站接入无线网络，通过电话与供应商的管理员联系以更新毫微微蜂窝接入用户列表的过程被省略，从而浪费时间减少，可以避免手动操作导致的故障。因此，操作时间长，操作过程复杂，访问错误率高等问题可以解决。因此，由本发明的实施例提供的方法，设备和通信系统可以提供用于更新列表的简单，快速和精确的方法，因此移动终端可以快速地访问无线网络。

9. 发明申请

WO2007070703A3 SINOMENINE DERIVATIVES AND PREPARATION AND USES THEREOF 审中-公开
标题翻译：化合物衍生物及其制备及其用途
公开(公告)号：WO2007070703A3
公开(公告)日：2007-12-06
申请号：PCT/US2006048086
申请日：2006-12-15
申请人： NATUREMED GROUP CORP , WANG JIE , PAN YI
发明人： WANG JIE , PAN YI
IPC分类号： A61K31/485 , C07D221/28
CPC分类号： C07D471/08 , C07D471/18
摘要： The present invention relates to the preparation and pharmacological use of sinomenine derivatives of formula I . The approach disclosed herein is the modification of D ring by- substituting for R. Additional substitutions in the other rings are also provided herein. Several of the sinomenine derivatives have significantly greater anti-inflammation activity when compared with the parent compound.
摘要翻译：本发明涉及式I的青藤碱衍生物的制备和药理学应用。本文公开的方法是通过R替代D环的修饰。本文还提供了其它环中的另外的取代。与母体化合物相比，几种青藤碱衍生物具有显着更高的抗炎活性。

10. 发明申请

WO2007070703A2 SINOMENINE DERIVATIVES AND PREPARATION AND USES THEREOF 审中-公开
标题翻译：青蒿素衍生物及其制备和用途
公开(公告)号：WO2007070703A2
公开(公告)日：2007-06-21
申请号：PCT/US2006/048086
申请日：2006-12-15
申请人： NATUREMED GROUP CORPORATION , WANG, Jie , PAN, Yi
发明人： WANG, Jie , PAN, Yi
IPC分类号： A61K31/553 , C07D491/22
CPC分类号： C07D471/08 , C07D471/18
摘要： The present invention relates to the preparation and pharmacological use of sinomenine derivatives of formula I . The approach disclosed herein is the modification of D ring by- substituting for R. Additional substitutions in the other rings are also provided herein. Several of the sinomenine derivatives have significantly greater anti-inflammation activity when compared with the parent compound.
摘要翻译：本发明涉及式I的青藤碱衍生物的制备和药理学应用。本文公开的方法是通过取代R的D环的修饰。本文还提供了其他环中的另外的取代。与母体化合物相比，几种青藤碱衍生物具有显着更高的抗炎活性。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式